glp 1 stomach upset GLP-1 and Gut Health: Addressing Metabolic Dysfunction for Physicians GLP-1 Intolerance and Endoscopic Sleeve

Healthcare providers typically monitor weight loss trajectory, assess tolerability of gastrointestinal effects, and may order laboratory tests including comprehensive metabolic panels to evaluate electrolyte status and kidney function

doi: 10.3389/fmicb.2021.630852 92 CorreaP

Semaglutide tends to be the better fit when: the goal is a 10 to 15 percent weight reduction, the patient has documented cardiovascular disease or is at high cardiovascular risk and wants the medication with the most outcomes data, cost or access constraints favor it, or the patient has tolerated single-pathway GLP-1s well in the past

Ceccarelli E, Guarino E, Merlotti D, Patti A, Luigi G, Nuti R, et al